TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

PADAGIS ISRAEL

DermatologyImmunologyNeurology
Generics

PADAGIS ISRAEL is a generic drug manufacturer focused on Dermatology, Immunology, Neurology. Key products include TESTOSTERONE.

2000
Since
49
Drugs
-
Trials
341
Approved (2yr)

Key Drugs

ADAPALENE AND BENZOYL PEROXIDE
adapalene
Retinoic acid receptor 1 indications · 2015
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
azelastine hydrochloride
Glucocorticoid Receptor 1 indications · 2017
GYNAZOLE-1
butoconazole nitrate
1 indications · 2012
CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
betamethasone dipropionate
Immunology
1 indications · 2013

Recent Activity

MUPIROCIN 2026-02-24
Labeling
MUPIROCIN 2026-02-24
Labeling
MUPIROCIN 2026-02-24
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-13
AMMONIUM LACTATE 2026-02-12
BRIMONIDINE TARTRATE 2026-02-11
Labeling
ESTRADIOL 2026-02-02
BETAMETHASONE DIPROPIONATE 2026-01-26
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Dermatology 38%
5 drugs
Immunology 23%
3 drugs
Neurology 15%
2 drugs
Oncology 15%
2 drugs
Gastroenterology 8%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Oncology, Dermatology, Immunology, Gastroenterology
Eli Lilly big-pharma
Oncology, Immunology, Neurology, Dermatology
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Gastroenterology, Neurology
Takeda big-pharma
Immunology, Oncology, Gastroenterology, Neurology
AbbVie big-pharma
Immunology, Oncology, Neurology